Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) SHH

20.70

-0.25(-1.19%)

Updated at June 03 10:55AM

Currency In CNY

Valuation

Market Cap4.51B
Enterprise Value2.37B
P/E Ratio-7.4
PEG Ratio5.14
Price/Sales Ratio3.92
Price/Book Ratio0.68
Enterprise/Revenue1.92
Enterprise/EBITDA-4.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.53
Operating Margin-0.51

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue947.38M
Revenue/Share5.34
Gross Profit958.99M
EBITDA-397.87M
Net Income-573.6M
Diluted EPS-2.93

Balance Sheet

Total Cash2.4B
Total Cash/Share12.53
Total Debt204.66M
Total Debt/Equity0.03
Current Ratio3.79
Book Value Per Share31.25

Price History

52-Week Change-16.4
52-Week High30.65
52-Week Low20.95
Moving Average 50 Days22.7
Moving Average 200 Days24.67

Statistics

Average Volume1.98M
Shares Outstanding191.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor6:5
Last Split DateJune 26, 2023